retatrutide phase 3 triumph First data, a of Science! Michael Weintraub, MD on X:

As an added bonus, Houshmand says that "peptides are safe for many patients," so there's not really any harm in trying them out

Pembrolizumab is standard adjuvant therapy for high-risk renal cell carcinoma, while belzutifan is recommended with managed access through the Cancer Drugs Fund, as an option for treating von HippelLindau (VHL) syndrome in adults who need treatment for VHL associated RCCs, central nervous system hemangioblastomas or pancreatic neuroendocrine tumours, when localised procedures are unsuitable or undesirable

Targeting early atherosclerosis: a focus on oxidative stress and inflammation

For example, in tissues and cells, the free radical oxidation of linoleic acid produces racemic mixtures of 13-hydroxy-9 Z ,11 E -octadecadienoic acid, 13-hydroxy-9 E ,11 E -octadecadienoic acid, 9-hydroxy-10 E ,12- E -octadecadienoic acid (9-EE-HODE), and 11-hydroxy-9 Z ,12- Z -octadecadienoic acid as well as 4-Hydroxynonenal while singlet oxygen attacks linoleic acid to produce (presumed but not yet proven to be racemic mixtures of) 13-hydroxy-9 Z ,11 E -octadecadienoic acid, 9-hydroxy-10 E ,12- Z -octadecadienoic acid, 10-hydroxy-8 E ,12 Z -octadecadienoic acid, and 12-hydroxy-9 Z -13- E -octadecadienoic (see 13-Hydroxyoctadecadienoic acid and 9-Hydroxyoctadecadienoic acid)